May 10, 2018 / 11:37 AM / 4 months ago

BRIEF-Strongbridge Biopharma Reports Q1 Non-GAAP Loss Per Share Of $0.33

May 10 (Reuters) - Strongbridge Biopharma plc:

* REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 NON-GAAP LOSS PER SHARE $0.33

* Q1 GAAP LOSS PER SHARE $0.66

* Q1 EARNINGS PER SHARE VIEW $-0.40 -- THOMSON REUTERS I/B/E/S

* INCREASED FULL-YEAR 2018 REVENUE GUIDANCE FOR KEVEYIS TO $18 TO $20 MILLION

* STRONGBRIDGE HAD $92.4 MILLION OF CASH AND CASH EQUIVALENTS AND $86.5 MILLION IN OUTSTANDING DEBT AS OF MARCH 31, 2018

* MACRILEN (MACIMORELIN) PRODUCT LAUNCH ON TRACK FOR JULY 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below